Mark Agostini

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease

Defining a pulmonary exacerbation in cystic fibrosis

Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species

Forebrain neurogenesis after focal Ischemic and traumatic brain injury

Microglial cell origin and phenotypes in health and disease

Defining an exacerbation of pulmonary disease in cystic fibrosis*

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Apolipoprotein E in Alzheimer's disease and other neurological disorders

The Influence of Exercise on Cognitive Abilities

Immunologic Aspects of Cystic Fibrosis

The Pathobiology of Vascular Dementia

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice

Outcome measures for clinical trials in cystic fibrosis Summary of a Cystic Fibrosis Foundation Consensus Conference

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

Meta-Analysis of APOE 4 Allele and Outcome after Traumatic Brain Injury

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Alzheimer's disease

The neuropathological diagnosis of Alzheimer’s disease

Antibacterial Therapy in Cystic Fibrosis

Posttraumatic epilepsy: The endophenotypes of a human model of epileptogenesis

Increased Risk of Late Posttraumatic Seizures Associated With Inheritance of APOE ϵ4 Allele

Retrospective case series of the clinical features, management and outcomes of patients with autoimmune epilepsy

Alternative antibiotics for the treatment of pseudomonas infections in cystic fibrosis